The Association for Clinical Oncology (ASCO) is one of nearly 50 specialty groups urging the National Institutes of Health (NIH) to rescind a recent policy change limiting how much research ...

To continue, please click on one of the buttons below or access other content through the navigation menu or search.

Multivariate model and incidence of VTE by MCS score. Incidence of VTE by MCS Score ...

The following is a message from the Director of the FDA Oncology Center of Excellence, Dr. Richard Pazdur: On February 11, 2025, the Food and Drug Administration approved brentuximab vedotin (Adcetris ...

“The TALAPRO-2 study showed a significant improvement in overall survival in men with mCRPC treated with the combination of talazoparib and enzalutamide whether they had HRR gene alterations. In this ...

ALEXANDRIA, Va. – Nine studies exploring new approaches for the treatment of genitourinary cancers will be presented at the upcoming 2025 American Society of Clinical Oncology (ASCO) Genitourinary ...

The American Society of Clinical Oncology (ASCO) is a medical professional oncology society committed to conquering cancer through research, education, prevention, and delivery of high-quality patient ...

This section provides key information on oncology events organized by ASCO or other organizations throughout the world. To submit an event, please fill out this form. Content on ASCO's Calendar of ...

What is Off-Label Use? A doctor can prescribe a US Food and Drug Administration (FDA) approved medication that is not yet approved to treat the specific type of cancer a person has. This is called ...

The American Society of Clinical Oncology (ASCO) is a professional oncology society committed to conquering cancer through research, education, prevention, and the delivery of high-quality patient ...

Founded in 1964, the American Society of Clinical Oncology is the world's leading professional organization for physicians and oncology professionals caring for people with cancer.